Aquilo Capital Management
Latest statistics and disclosures from Aquilo Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are XBI, MRUS, Loxo Oncology, FATE, Aduro Biotech, and represent 75.84% of Aquilo Capital Management's stock portfolio.
- Added to shares of these 8 stocks: XBI (+$48M), Synlogic (+$9.8M), XENE (+$7.8M), FATE (+$6.6M), SPRO, MRUS, Aduro Biotech, CTMX.
- Started 1 new stock position in XENE.
- Reduced shares in these 6 stocks: AUTL, GLPG, CLLS, Loxo Oncology, Five Prime Therapeutics, MOR.
- Sold out of its positions in AUTL, CLLS, Five Prime Therapeutics.
- Aquilo Capital Management was a net buyer of stock by $63M.
- Aquilo Capital Management has $239M in assets under management (AUM), dropping by 96.46%.
- Central Index Key (CIK): 0001750122
Tip: Access up to 7 years of quarterly data
Positions held by Aquilo Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 12 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 44.1 | $106M | +83% | 1.1M | 95.87 |
|
| Merus N V (MRUS) | 10.7 | $26M | +3% | 1.3M | 19.74 |
|
| Loxo Oncology | 7.8 | $19M | -13% | 109k | 170.83 |
|
| Fate Therapeutics (FATE) | 6.7 | $16M | +69% | 985k | 16.29 |
|
| Aduro Biotech | 6.5 | $16M | +4% | 2.1M | 7.35 |
|
| Synlogic | 5.9 | $14M | +225% | 998k | 14.21 |
|
| Cytomx Therapeutics (CTMX) | 5.2 | $13M | +3% | 675k | 18.50 |
|
| Pieris Pharmaceuticals | 4.6 | $11M | 2.0M | 5.60 |
|
|
| Spero Therapeutics (SPRO) | 3.5 | $8.4M | +91% | 800k | 10.51 |
|
| Xenon Pharmaceuticals (XENE) | 3.3 | $7.8M | NEW | 593k | 13.20 |
|
| Galapagos Nv- (GLPG) | 1.5 | $3.5M | -52% | 31k | 112.42 |
|
| Morphosys (MOR) | 0.1 | $243k | -9% | 9.1k | 26.74 |
|
Past Filings by Aquilo Capital Management
SEC 13F filings are viewable for Aquilo Capital Management going back to 2018
- Aquilo Capital Management 2018 Q3 filed Nov. 14, 2018
- Aquilo Capital Management 2018 Q2 filed Aug. 14, 2018